Leo Cancer Care raises $65M to expand upright radiotherapy and imaging production

Leo Cancer Care has secured $65 million in funding to scale manufacturing of its upright radiology solutions, including proton therapy, photon therapy, and imaging systems.

• The funding will support scaling production of upright patient positioning and imaging devices for proton and photon therapy.
• The company's solutions aim to integrate imaging and treatment in a vertical orientation, potentially reducing footprint and cost.
• No specific clinical trial data or regulatory milestones were disclosed in the announcement.

RadPigeon summaries are original and for information only. They are not clinical advice.